INTRODUCTION
This study was undertaken to prove hypothesis that polysaccharide from Helianthus tuberosus L. has antimetastatic and antitumor activities due to immunomodulating activity and proapoptotic activities in tumors, by triggering cytokines cascades, activating immune system especially Nk-cells and colonystimulation.
Such an approach to the antitumor therapy and preventing metastasis, which is based on the activation of innate immune system -stimulation of Nk-cells activity,what leads to thegrowth of the cytotoxicity index, cytokines cascades, and apoptosis in tumor cells can be considered as a development of immune therapy of cancer [1, 2] .
At the same time various scientific groups proved broad range of polysaccharide activity, especially immunological [3] [4] [5] . Moreover it was shown that polysaccharides can demonstrate antitumor [6] , antimetastatic, what was shown for glucan structurally similar to HTLP [7] , cytotoxic and apoptosis stimulating in tumor cells K562 anf Hep-2 [8, 9] , activity in wide variety of biological both in vivo and in vitro models. Some of authors propose that polysaccharides have antitumor, antimetastatic activity due to immunological activity [10] .The polysaccharide from Helianthus tuberosus L. was studied as immunomodulatory in previous work in different models and influencing different cytokines IL-1, IL-6, TNF [3] .
It is proposed that polysaccharide from Helianthus tuberosus L. possess immunomodulatory activity and activation of immune system that strikes tumor and metastases.
Laboratory Animals
Experiments were performed in 100-130 g «Avgust»breed ratsand 20-25 g C57BL/6 inbred mice, from Stolbovaya nursery of the Russian Academy of Medical Sciences. In tests were used both male and female rats and mice.
Experimental models

Stimulation of Nk-cells activity by HTLP
For in vitro study of influence of HTLP on the activity of Nk-cells human myeloleucosis (K-562) as a target cells, stained with 3H-uridin in 3 µCi per 1 ml of culture media were taken. K-562 cell line then was used in amount 105 per experimental point. As an effector cells peripheral blood lymphocytes (PBL) were taken. For that human blood from 5 donors, after test for immune status, was incubated with 100 U/ml heparin and diluted 1:2 with balance saline and layered on the phycoll-sodium metriozat, with density 1.077. After that solution was centrifuged for 15 minutes at 1000 g. PBL layer, which formed on the boundary between the plasma-phycoll, was collected and washed twice in a balanced saline solution. To check cytotoxic reaction PBL from donors with normal immune status were taken. Effector cells were cultivated in vitro with 100 µg/well HTLP in U-bottom 96-well plate for 24 hours. In each well was placed 100 µl of effector cell suspension in total 107 cells and target cells at a ratio 100:1 and 10 µl of RNase (5 µg/ml). Each dilution was repeated 5 times. Target cells without effector cells and target cells incubated with HTLP (same amount) were used as a control. Plate was incubated in CO2 incubator for 14 hours. The well contents transferred via harvester on filters (Whatman) and washed with saline, then with 5% trichloroacetic acid solution and 95% ethanol. The dried filters were placed in vials containing scintillation fluid.
In Vitro Antitumor Activity of HTLP
In the in vitro study human laryngeal carcinoma Hep-2 and murine aneuploidy fibrosarcoma L-929 were used. Duration of contact with the culture and polysaccharide was 24 hours. Evaluation of the drug action was made by counting the viable tumor cells staining with trypan blue, their comparison with the control cultures, and calculating the percentage of inhibition of cell growth.
In vivo antimetastatic activity of HTLP in Walker carcinosarcoma model
For in vivo study high-affinity strain of Walker carcinosarcoma was used. To study the effect of drugs on tumor cell metastasis convenient models are strains of transplantable tumors with selective cells organotropye and enhanced colonogenic capacity in conditions in vivo. To identify anti-tumor activity of the HTLP was used affinity strain of Walker carcinosarcoma which at inoculation into the tail vein of the «August»rats male and female 100-130 g weigh, forms tumor nodules in the lungs. HTLP was injected subcutaneously at a dose of 0.015 and 1.0 mg/kg daily, in different schedule. Clones were enucleated from rat lungs after decapitation. Different groups were formed:
1. Control -injection into tail vein of 0.2 ml of 0.9% NaCl. Killing was performed on the 5 day after inoculation of tumor. 2. Control injection into tail vein of 0.2 ml of 0.9% NaCl. Killing was performed on the 10 day after inoculation of tumor. 3. Injection of HTLP in amount 0.015 mg/kg after 3 days after inoculation every day. Killing was performed on the 5 day after first injection. 4. Injection of HTLP in amount 0.015 mg/kg after 3 days after inoculation every day. Killing was performed on the 10 day after first injection. 5. Injection of HTLP in amount 1.0 mg/kg after 3 days after inoculation each 2 days. Killing was performed on the 5 day after first injection. 6. Injection of HTLP in amount 1.0 mg/kg after 3 days after inoculation each 2 days. Killing was performed on the 10 day after first injection.
2.3.4.In vivo antitumor and antimetastatic activity of HTLP in Lewis lung-carcinoma (LLC) model
Shredded pieces of LLC tumor tissue were interwoven intramuscularly into mice back leg femoris. During tumor development in mice primary tumor weight was measured 5 times on 5, 11, 14, 17 and 20 day after tumor injection as a difference between weight of leg with tumor and without. Lungs weight and number of tumor cells colonies (lungs were fixed in Bowen solution) were also measured. 0.9% NaCl solution of HTLP was injected subcutaneously on the 4 day after tumor injection in 0.5 and 5 mg/kg doses. Two course were studied -single and fivefold injection. After animal slaughter tumor tissues were taken for histology. To study antimetastatic activity of polysaccharide solution number of lung metastases was counted directly.
RESULTS AND DISCUSSION
Stimulation of Nk-Cells Activity by HTLP
In table 1 influence of HTLP on the activity of Nk-cells is shown. Cytotoxicity index (CI) was calculated using equation: CI = (1-A/B)×100%, where A -number of impulses in test-wells, Bnumber of impulses in control wells. CI for K562 + PBL = 61.0 ± 2.7 and for K562 + PBL + HTLP = 76.0 ± 3.1. Therefor growth of CI was 15.0% comparing with K562 + PBL group. In this experiment polysaccharide stimulated activity of Nk-cells in vitro. 
Table1.Influence of HTLP on activity of Nk-cells.
In Vitro Antitumor Activity of HTLP
The Tables 3 and 4 show that this substance has antimetastatic activity at high -100 γper animal and at low concentrations -1.5 γper animal. Moreover the similarity of antimetastatic activity of higher and lower doses with different time courses shows that biological effect of HTLP bases not only on the direct impact of the substance on the metastases, such as activation of apoptosis, but also on the trigger activation of the immune system. Such result corresponds with previous works, where was shown immunomodulatory activity and antiviral activity of HTLP in the way of stabilization of different cytokines [2, 3] and stimulation of phagocytosis and with Nk-cells activity stimulation experiment. 
In Vivo Antimetastatic Activity of HTLP In Walker Carcinosarcoma Model
3.4.In Vivo Antitumor And Antimetastatic Activity of HTLP In Lewis Lung-Carcinoma (LLC) Model
Influence of HTLP on weight of LLC primary tumor is shown in table 5. Difference in tumor-growth kinetics between treated and control animals served as the indictor of the growth-inhibition effect. The coefficient of tumor growth inhibition (TGI, %) was determined according to the following relationship: TGI = 1 -PT/PC, where P is the weight of tumor in C -control, T -trial group. The maximum TGI obtained is 15%. However, histologically tumors from trial group and control differin control group necrosis started in central part on 14 day after LLC injection, in trial groups this process started on 11 day, and at 20 day was more widespread than in control. Such activity could be explained through immunological mechanism by activation of macrophages and Nk-cells. Probably course must be prolonged to reveal more explicit antitumor activity of HTLP. Table 6 shows influence of polysaccharide from Helianthus tuberosus L. on the metastatic process. On the 14 day after injection of LLC there were up to 11 colonies of cancer cells in lungs in control group. Injection of 5 mg/kg (100 γper animal) effectively inhibits metastasis up to 60% comparing with control. On the 17 day antimetastatic effect was also observed in all trial groups comparing with control. The maximum antimetastatic activity of HTLP was observed in the group with single
